Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Case Report

BTDMJB. 2014; 10(2): 75-77


Radioiodine therapy for hyperthyroidism in a patient with end-stage renal disease on hemodialysis: case report

Müge Tamam, Mehmet Mülazımoğlu, Nurcan Edis, Ercan Uyanık, Tevfik Özpaçacı.

Abstract
Toxic nodular goiter is a rare entity in end-stage renal disaese (ESRD) patients. In ESRD patients, hypothyroidism is generally seen, whereas hyperthyroidism is rare. Treatment with radioactive iodine (RAI) may be necessary for hyperthyroidism in patients with end-stage renal disease who require haemodialysis. Because RAI is cleared mainly by the kidneys in patients with normal renal function, many problems may (issues) arise in patients who are on hemodialysis but require RAI treatment. We present an ESRD patient with hyperthyroidism who is receiving hemodialysis treated with radioiodine therapy.

Key words: Hyperthyroidism, hemodialysis, radioiodine theraphy



Article Language: Turkish English



Share this Article


Advertisement
Applied Medical Research

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons